Industry: Medical Devices & Consumables
Published Date: 2025-03-10
Pages: 79 Pages
Report ld: 4613005
Request Sample
Customized Report
Stereotactic Radiation Therapy (SRT) System Market Size(US$)

CAGR 2025-2031
23.2%
Market Size,2031
USD 1,249
Million
Market Snapshot
Source: Secondary research, interviews with experts, and QYResearch analysis
The global market for Stereotactic Radiation Therapy (SRT) System was valued at US$ 296 million in the year 2024 and is projected to reach a revised size of US$ 1249 million by 2031, growing at a CAGR of 23.2% during the forecast period.
Improvements in tumor localization, imaging and dosimetry in radiotherapy has allowed for the implementation of hypofractionated radiotherapy for disease sites where conventional fractionation (around 2 Gy per fraction) was previously the norm or where curative radiotherapy was not attempted. SRT comprises high-precision irradiation techniques that use multiple, photon radiation beams to deliver a high dose of radiation. Stereotactic localization, using frame-based or frameless techniques, is used to treat lesions. Regarding dose fractionation, SRT is divided into stereotactic radiosurgery (SRS), in which the total dose is delivered in a single treatment session, and stereotactic radiotherapy, in which the total dose is delivered in multiple fractions (usually less than 8 treatments). Originally this technique was only used when treating lesions located in the brain, however now a number of extra-cranial malignancies are treated using stereotactic localization (stereotactic body radiotherapy (SBRT)).
North American market for Stereotactic Radiation Therapy (SRT) System is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
Asia-Pacific market for Stereotactic Radiation Therapy (SRT) System is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
The major global manufacturers of Stereotactic Radiation Therapy (SRT) System include Elekta, Accuray Incorporated, MASEP Medical Science & Technology Development (Shenzhen), China Isotope & Radiation Corporation, Huiheng Group, OUR United Gorp, Jiangsu Rayer Medical Technology, Hygeia Healthcare Holdings, etc. In 2024, the world's top three vendors accounted for approximately % of the revenue.
REPORT SCOPE
This report aims to provide a comprehensive presentation of the global market for Stereotactic Radiation Therapy (SRT) System, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Stereotactic Radiation Therapy (SRT) System.
The Stereotactic Radiation Therapy (SRT) System market size, estimations, and forecasts are provided in terms of sales volume (Units) and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Stereotactic Radiation Therapy (SRT) System market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Stereotactic Radiation Therapy (SRT) System manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
By Company
Elekta
Accuray Incorporated
MASEP Medical Science & Technology Development (Shenzhen)
China Isotope & Radiation Corporation
Huiheng Group
OUR United Gorp
Jiangsu Rayer Medical Technology
Hygeia Healthcare Holdings
Segment by Type
X-rays
Gamma-rays
Segment by Application
Hospital
Clinic
Other
Consumption by Region
North America
United States
Canada
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Southeast Asia
Europe
Germany
France
U.K.
Italy
Russia
Latin America
Mexico
Brazil
Argentina
Colombia
Middle East and Africa
Turkey
Saudi Arabia
UAE
Core Chapters
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Stereotactic Radiation Therapy (SRT) System manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Stereotactic Radiation Therapy (SRT) System in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
QYRESEARCH'S STRENGTHS
Unlike generic global market reports, this study combines macro-level industry trends with hyper-local operational intelligence, empowering data-driven decisions across the Compound Chocolate value chain, addressing:
We identify regional market threats and growth prospects to guide your overseas layout.
We adjust product portfolios in line with local consumption habits.
We unpack rivals’ operation strategies for scattered and highly concentrated industries.
We cover competition landscape, full supply chain and quantified market size data, and deliver tailor-made customized surveys to meet your unique business demands.
We own self-owned massive exclusive databases, backed by 19 years of global market research experience across thousands of sectors.
Our team operates 24 hours a day, 365 days a year, enabling ultra-fast report turnaround to respond to your research needs efficiently.
We integrate regional risk assessment, localized product optimization and competitor analysis to deliver actionable market strategies.
All data is cross-verified from multiple industry sources to deliver thorough, precise analysis that supports reliable corporate strategic decisions.
We provide responsive, dedicated after-sales support to resolve all follow-up inquiries about reports, data and industry interpretation.
TABLE OF CONTENTS
1 Stereotactic Radiation Therapy (SRT) System Market Overview
1.1 Product Definition
1.2 Stereotactic Radiation Therapy (SRT) System by Type
1.2.1 Global Stereotactic Radiation Therapy (SRT) System Market Value Comparison by Type (2024 VS 2031)
1.2.2 X-rays
1.2.3 Gamma-rays
1.3 Stereotactic Radiation Therapy (SRT) System by Application
1.3.1 Global Stereotactic Radiation Therapy (SRT) System Market Value by Application (2024 VS 2031)
1.3.2 Hospital
1.3.3 Clinic
1.3.4 Other
1.4 Global Stereotactic Radiation Therapy (SRT) System Market Size Estimates and Forecasts
1.4.1 Global Stereotactic Radiation Therapy (SRT) System Revenue 2020-2031
1.4.2 Global Stereotactic Radiation Therapy (SRT) System Sales 2020-2031
1.4.3 Global Stereotactic Radiation Therapy (SRT) System Market Average Price (2020-2031)
1.5 Assumptions and Limitations
2 Stereotactic Radiation Therapy (SRT) System Market Competition by Manufacturers
2.1 Global Stereotactic Radiation Therapy (SRT) System Sales Market Share by Manufacturers (2020-2025)
2.2 Global Stereotactic Radiation Therapy (SRT) System Revenue Market Share by Manufacturers (2020-2025)
2.3 Global Stereotactic Radiation Therapy (SRT) System Average Price by Manufacturers (2020-2025)
2.4 Global Key Players of Stereotactic Radiation Therapy (SRT) System, Industry Ranking, 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Stereotactic Radiation Therapy (SRT) System, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Stereotactic Radiation Therapy (SRT) System, Product Type & Application
2.7 Global Key Manufacturers of Stereotactic Radiation Therapy (SRT) System, Date of Enter into This Industry
2.8 Global Stereotactic Radiation Therapy (SRT) System Market Competitive Situation and Trends
2.8.1 Global Stereotactic Radiation Therapy (SRT) System Market Concentration Rate
2.8.2 The Global 5 and 10 Largest Stereotactic Radiation Therapy (SRT) System Players Market Share by Revenue
2.8.3 Global Stereotactic Radiation Therapy (SRT) System Company Type and Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
2.9 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Global Stereotactic Radiation Therapy (SRT) System Market Scenario by Region
3.1 Global Stereotactic Radiation Therapy (SRT) System Market Size by Region: 2020 Versus 2024 Versus 2031
3.2 Global Stereotactic Radiation Therapy (SRT) System Sales by Region: 2020-2031
3.2.1 Global Stereotactic Radiation Therapy (SRT) System Sales by Region: 2020-2025
3.2.2 Global Stereotactic Radiation Therapy (SRT) System Sales by Region: 2026-2031
3.3 Global Stereotactic Radiation Therapy (SRT) System Revenue by Region: 2020-2031
3.3.1 Global Stereotactic Radiation Therapy (SRT) System Revenue by Region: 2020-2025
3.3.2 Global Stereotactic Radiation Therapy (SRT) System Revenue by Region: 2026-2031
3.4 North America Stereotactic Radiation Therapy (SRT) System Market Facts & Figures by Country
3.4.1 North America Stereotactic Radiation Therapy (SRT) System Market Size by Country: 2020 VS 2024 VS 2031
3.4.2 North America Stereotactic Radiation Therapy (SRT) System Sales by Country (2020-2031)
3.4.3 North America Stereotactic Radiation Therapy (SRT) System Revenue by Country (2020-2031)
3.4.4 United States
3.4.5 Canada
3.5 Europe Stereotactic Radiation Therapy (SRT) System Market Facts & Figures by Country
3.5.1 Europe Stereotactic Radiation Therapy (SRT) System Market Size by Country: 2020 VS 2024 VS 2031
3.5.2 Europe Stereotactic Radiation Therapy (SRT) System Sales by Country (2020-2031)
3.5.3 Europe Stereotactic Radiation Therapy (SRT) System Revenue by Country (2020-2031)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Stereotactic Radiation Therapy (SRT) System Market Facts & Figures by Region
3.6.1 Asia Pacific Stereotactic Radiation Therapy (SRT) System Market Size by Region: 2020 VS 2024 VS 2031
3.6.2 Asia Pacific Stereotactic Radiation Therapy (SRT) System Sales by Region (2020-2031)
3.6.3 Asia Pacific Stereotactic Radiation Therapy (SRT) System Revenue by Region (2020-2031)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Southeast Asia
3.7 Latin America Stereotactic Radiation Therapy (SRT) System Market Facts & Figures by Country
3.7.1 Latin America Stereotactic Radiation Therapy (SRT) System Market Size by Country: 2020 VS 2024 VS 2031
3.7.2 Latin America Stereotactic Radiation Therapy (SRT) System Sales by Country (2020-2031)
3.7.3 Latin America Stereotactic Radiation Therapy (SRT) System Revenue by Country (2020-2031)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.7.7 Colombia
3.8 Middle East and Africa Stereotactic Radiation Therapy (SRT) System Market Facts & Figures by Country
3.8.1 Middle East and Africa Stereotactic Radiation Therapy (SRT) System Market Size by Country: 2020 VS 2024 VS 2031
3.8.2 Middle East and Africa Stereotactic Radiation Therapy (SRT) System Sales by Country (2020-2031)
3.8.3 Middle East and Africa Stereotactic Radiation Therapy (SRT) System Revenue by Country (2020-2031)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Stereotactic Radiation Therapy (SRT) System Sales by Type (2020-2031)
4.1.1 Global Stereotactic Radiation Therapy (SRT) System Sales by Type (2020-2025)
4.1.2 Global Stereotactic Radiation Therapy (SRT) System Sales by Type (2026-2031)
4.1.3 Global Stereotactic Radiation Therapy (SRT) System Sales Market Share by Type (2020-2031)
4.2 Global Stereotactic Radiation Therapy (SRT) System Revenue by Type (2020-2031)
4.2.1 Global Stereotactic Radiation Therapy (SRT) System Revenue by Type (2020-2025)
4.2.2 Global Stereotactic Radiation Therapy (SRT) System Revenue by Type (2026-2031)
4.2.3 Global Stereotactic Radiation Therapy (SRT) System Revenue Market Share by Type (2020-2031)
4.3 Global Stereotactic Radiation Therapy (SRT) System Price by Type (2020-2031)
5 Segment by Application
5.1 Global Stereotactic Radiation Therapy (SRT) System Sales by Application (2020-2031)
5.1.1 Global Stereotactic Radiation Therapy (SRT) System Sales by Application (2020-2025)
5.1.2 Global Stereotactic Radiation Therapy (SRT) System Sales by Application (2026-2031)
5.1.3 Global Stereotactic Radiation Therapy (SRT) System Sales Market Share by Application (2020-2031)
5.2 Global Stereotactic Radiation Therapy (SRT) System Revenue by Application (2020-2031)
5.2.1 Global Stereotactic Radiation Therapy (SRT) System Revenue by Application (2020-2025)
5.2.2 Global Stereotactic Radiation Therapy (SRT) System Revenue by Application (2026-2031)
5.2.3 Global Stereotactic Radiation Therapy (SRT) System Revenue Market Share by Application (2020-2031)
5.3 Global Stereotactic Radiation Therapy (SRT) System Price by Application (2020-2031)
6 Key Companies Profiled
6.1 Elekta
6.1.1 Elekta Company Information
6.1.2 Elekta Description and Business Overview
6.1.3 Elekta Stereotactic Radiation Therapy (SRT) System Sales, Revenue and Gross Margin (2020-2025)
6.1.4 Elekta Stereotactic Radiation Therapy (SRT) System Product Portfolio
6.1.5 Elekta Recent Developments/Updates
6.2 Accuray Incorporated
6.2.1 Accuray Incorporated Company Information
6.2.2 Accuray Incorporated Description and Business Overview
6.2.3 Accuray Incorporated Stereotactic Radiation Therapy (SRT) System Sales, Revenue and Gross Margin (2020-2025)
6.2.4 Accuray Incorporated Stereotactic Radiation Therapy (SRT) System Product Portfolio
6.2.5 Accuray Incorporated Recent Developments/Updates
6.3 MASEP Medical Science & Technology Development (Shenzhen)
6.3.1 MASEP Medical Science & Technology Development (Shenzhen) Company Information
6.3.2 MASEP Medical Science & Technology Development (Shenzhen) Description and Business Overview
6.3.3 MASEP Medical Science & Technology Development (Shenzhen) Stereotactic Radiation Therapy (SRT) System Sales, Revenue and Gross Margin (2020-2025)
6.3.4 MASEP Medical Science & Technology Development (Shenzhen) Stereotactic Radiation Therapy (SRT) System Product Portfolio
6.3.5 MASEP Medical Science & Technology Development (Shenzhen) Recent Developments/Updates
6.4 China Isotope & Radiation Corporation
6.4.1 China Isotope & Radiation Corporation Company Information
6.4.2 China Isotope & Radiation Corporation Description and Business Overview
6.4.3 China Isotope & Radiation Corporation Stereotactic Radiation Therapy (SRT) System Sales, Revenue and Gross Margin (2020-2025)
6.4.4 China Isotope & Radiation Corporation Stereotactic Radiation Therapy (SRT) System Product Portfolio
6.4.5 China Isotope & Radiation Corporation Recent Developments/Updates
6.5 Huiheng Group
6.5.1 Huiheng Group Company Information
6.5.2 Huiheng Group Description and Business Overview
6.5.3 Huiheng Group Stereotactic Radiation Therapy (SRT) System Sales, Revenue and Gross Margin (2020-2025)
6.5.4 Huiheng Group Stereotactic Radiation Therapy (SRT) System Product Portfolio
6.5.5 Huiheng Group Recent Developments/Updates
6.6 OUR United Gorp
6.6.1 OUR United Gorp Company Information
6.6.2 OUR United Gorp Description and Business Overview
6.6.3 OUR United Gorp Stereotactic Radiation Therapy (SRT) System Sales, Revenue and Gross Margin (2020-2025)
6.6.4 OUR United Gorp Stereotactic Radiation Therapy (SRT) System Product Portfolio
6.6.5 OUR United Gorp Recent Developments/Updates
6.7 Jiangsu Rayer Medical Technology
6.7.1 Jiangsu Rayer Medical Technology Company Information
6.7.2 Jiangsu Rayer Medical Technology Description and Business Overview
6.7.3 Jiangsu Rayer Medical Technology Stereotactic Radiation Therapy (SRT) System Sales, Revenue and Gross Margin (2020-2025)
6.7.4 Jiangsu Rayer Medical Technology Stereotactic Radiation Therapy (SRT) System Product Portfolio
6.7.5 Jiangsu Rayer Medical Technology Recent Developments/Updates
6.8 Hygeia Healthcare Holdings
6.8.1 Hygeia Healthcare Holdings Company Information
6.8.2 Hygeia Healthcare Holdings Description and Business Overview
6.8.3 Hygeia Healthcare Holdings Stereotactic Radiation Therapy (SRT) System Sales, Revenue and Gross Margin (2020-2025)
6.8.4 Hygeia Healthcare Holdings Stereotactic Radiation Therapy (SRT) System Product Portfolio
6.8.5 Hygeia Healthcare Holdings Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Stereotactic Radiation Therapy (SRT) System Industry Chain Analysis
7.2 Stereotactic Radiation Therapy (SRT) System Raw Material Supply Analysis
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Stereotactic Radiation Therapy (SRT) System Production Mode & Process Analysis
7.4 Stereotactic Radiation Therapy (SRT) System Sales and Marketing
7.4.1 Stereotactic Radiation Therapy (SRT) System Sales Channels
7.4.2 Stereotactic Radiation Therapy (SRT) System Distributors
7.5 Stereotactic Radiation Therapy (SRT) System Customer Analysis
8 Stereotactic Radiation Therapy (SRT) System Market Dynamics
8.1 Stereotactic Radiation Therapy (SRT) System Industry Trends
8.2 Stereotactic Radiation Therapy (SRT) System Market Drivers
8.3 Stereotactic Radiation Therapy (SRT) System Market Challenges
8.4 Stereotactic Radiation Therapy (SRT) System Market Restraints
9 Research Findings and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
TABLE OF FIGURES
List of Tables
List of Figures
KEY QUESTIONS ADDRESSED BY THE REPORT
Related Reports
The global Stereotactic Radiation Therapy (SRT) System market is projected to grow from US$ 357 million in 2025 to US$ 1510 million by 2032, at a CAGR of 23.2% (2026-2032), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
Published Date: 2026-03-25
Pages: 133
USD 4900.00
(Single User License)
The global Stereotactic Radiation Therapy (SRT) System market size was US$ 357 million in 2025 and is forecast to reach a readjusted size of US$ 1510 million by 2032 with a CAGR of 23.2% during the forecast period 2026-2032.
Published Date: 2026-03-25
Pages: 80
USD 4250.00
(Single User License)
The global Stereotactic Radiation Therapy (SRT) System market was valued at US$ 357 million in 2025 and is anticipated to reach US$ 1510 million by 2032, at a CAGR of 23.2% from 2026 to 2032.
Published Date: 2026-01-08
Pages: 115
USD 2900.00
(Single User License)
The global market for Stereotactic Radiation Therapy (SRT) System was estimated to be worth US$ 357 million in 2025 and is projected to reach US$ 1510 million, growing at a CAGR of 23.2% from 2026 to 2032.
Published Date: 2026-01-08
Pages: 100
USD 3950.00
(Single User License)
The global Stereotactic Radiation Therapy (SRT) System market size was US$ 296 million in 2024 and is forecast to a readjusted size of US$ 1249 million by 2031 with a CAGR of 23.2% during the forecast period 2025-2031.
Published Date: 2025-08-01
Pages: 78
USD 4250.00
(Single User License)
The global Stereotactic Radiation Therapy (SRT) System market is projected to grow from US$ 296 million in 2024 to US$ 1249 million by 2031, at a CAGR of 23.2% (2025-2031), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
Published Date: 2025-08-01
Pages: 150
USD 4900.00
(Single User License)
The global market for Stereotactic Radiation Therapy (SRT) System was estimated to be worth US$ 296 million in 2024 and is forecast to a readjusted size of US$ 1249 million by 2031 with a CAGR of 23.2% during the forecast period 2025-2031.
Published Date: 2025-03-10
Pages: 107
USD 3950.00
(Single User License)
The global Stereotactic Radiation Therapy (SRT) System market is projected to grow from US$ 296 million in 2024 to US$ 1034 million by 2030, at a Compound Annual Growth Rate (CAGR) of 23.2% during the forecast period.
Published Date: 2024-11-15
Pages: 133
USD 4900.00
(Single User License)
The global Stereotactic Radiation Therapy (SRT) System revenue was US$ 259 million in 2023 and is forecast to a readjusted size of US$ 1034 million by 2030 with a CAGR of 23.2% during the review period (2024-2030).
Published Date: 2024-11-15
Pages: 116
USD 4350.00
(Single User License)
The global market for Stereotactic Radiation Therapy (SRT) System was estimated to be worth US$ 259 million in 2023 and is forecast to a readjusted size of US$ 1034 million by 2030 with a CAGR of 23.2% during the forecast period 2024-2030.
Published Date: 2024-11-15
Pages: 93
USD 3950.00
(Single User License)
The global Stereotactic Radiation Therapy (SRT) System market is projected to grow from US$ 357 million in 2025 to US$ 1510 million by 2032, at a CAGR of 23.2% (2026-2032), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
Published: 2026-03-25
Pages: 133
The global Stereotactic Radiation Therapy (SRT) System market size was US$ 357 million in 2025 and is forecast to reach a readjusted size of US$ 1510 million by 2032 with a CAGR of 23.2% during the forecast period 2026-2032.
Published: 2026-03-25
Pages: 80
The global Stereotactic Radiation Therapy (SRT) System market was valued at US$ 357 million in 2025 and is anticipated to reach US$ 1510 million by 2032, at a CAGR of 23.2% from 2026 to 2032.
Published: 2026-01-08
Pages: 115
The global market for Stereotactic Radiation Therapy (SRT) System was estimated to be worth US$ 357 million in 2025 and is projected to reach US$ 1510 million, growing at a CAGR of 23.2% from 2026 to 2032.
Published: 2026-01-08
Pages: 100
The global Stereotactic Radiation Therapy (SRT) System market size was US$ 296 million in 2024 and is forecast to a readjusted size of US$ 1249 million by 2031 with a CAGR of 23.2% during the forecast period 2025-2031.
Published: 2025-08-01
Pages: 78
The global Stereotactic Radiation Therapy (SRT) System market is projected to grow from US$ 296 million in 2024 to US$ 1249 million by 2031, at a CAGR of 23.2% (2025-2031), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
Published: 2025-08-01
Pages: 150
The global market for Stereotactic Radiation Therapy (SRT) System was estimated to be worth US$ 296 million in 2024 and is forecast to a readjusted size of US$ 1249 million by 2031 with a CAGR of 23.2% during the forecast period 2025-2031.
Published: 2025-03-10
Pages: 107
The global Stereotactic Radiation Therapy (SRT) System market is projected to grow from US$ 296 million in 2024 to US$ 1034 million by 2030, at a Compound Annual Growth Rate (CAGR) of 23.2% during the forecast period.
Published: 2024-11-15
Pages: 133
The global Stereotactic Radiation Therapy (SRT) System revenue was US$ 259 million in 2023 and is forecast to a readjusted size of US$ 1034 million by 2030 with a CAGR of 23.2% during the review period (2024-2030).
Published: 2024-11-15
Pages: 116
The global market for Stereotactic Radiation Therapy (SRT) System was estimated to be worth US$ 259 million in 2023 and is forecast to a readjusted size of US$ 1034 million by 2030 with a CAGR of 23.2% during the forecast period 2024-2030.
Published: 2024-11-15
Pages: 93
REPORT COVERAGE
DESCRIPTION
OVERVIEW
REPORT SCOPE
QYRESEARCH'S STRENGTHS
TABLE OF CONTENTS
TABLE OF FIGURES
RLEATED REPORTS
INTEREST IN THIS REPORT?
Get A Free Sample
Request For Quotation
OR
NEED A CUSTOMIZED REPORT?
Customized Report
Request Sample
Pre-Order Enquiry
Add to Cart
Buy Now